共 229 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2019)The hepatocellular carcinoma market Nat Rev Drug Discov 18 13-14
[3]
Soerjomataram I(2014)The role of inflammation and liver cancer Adv Exp Med Biol 816 401-435
[4]
Siegel RL(2019)Immunotherapy in hepatocellular carcinoma Ann Hepatol 18 291-297
[5]
Torre LA(2013)Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma Nat Rev Cancer 13 123-135
[6]
Jemal A(2016)Hepatocellular carcinoma Nat Rev Dis Primers 2 16018-943
[7]
Dawkins J(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-331
[8]
Webster RM(2014)Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity Int J Cancer 134 319-390
[9]
Bishayee A(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-1022
[10]
Buonaguro L(2013)Innate and adaptive immune cells in the tumor microenvironment Nat Immunol 14 1014-960